Z-0111-04
DomiVisc Sodium Hyaluronate 0.8 mL 12 mg.mL Syringe. Sterile.RX. For intraocular use Product Numbner...
Anika Therapeutics, Inc. / initiated 2003-10-08 / Terminated
Anika Therapeutics began a recall of DomiVisc Sodium Hyaluronate 0.8 mL 12 mg.mL Syringe. Sterile.RX. For intraocular use Product Numbner; P012-180A Manufactured for Bausch & Lomb on . The reason FDA records is "Stability failure at the 20 month for viscosity specification". As of , the recall status on record is Terminated.
Recall record
- Recall number
- Z-0111-04
- Status
- Terminated
- Initiated
- Posted
- Terminated
- Recalling firm
- Anika Therapeutics, Inc.
- Product
- DomiVisc Sodium Hyaluronate 0.8 mL 12 mg.mL Syringe. Sterile.RX. For intraocular use Product Numbner; P012-180A Manufactured for Bausch & Lomb
- Product code
- LZP Aid, Surgical, Viscoelastic
- Reason for recall
- Stability failure at the 20 month for viscosity specification
- FDA root cause
- Other
- Action
- Anika Therapeutics issued notification on 10/8/2003 by fax and FedEx to three Distributors. Distributors were requested to subrecall to their customers.
- Quantity in commerce
- 4948 units
- Distribution
- CA, MO, NC,VA
- Product codes and lots
- Lot Numbers: B020122A, B020122J
FIRST ARTICLE / WEEKLY
What cleared, what was recalled, and what changed in the standards. One edition a week for the people who make medical devices.
